Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.

J Clin Med · 2024 · PMC11355214 · PMID 39200816

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In contrast, the studies for exenatide, lisixenatide and oral semaglutide did not reach statistical significance for superiority compared to placebo [ 53 , 55 , 58 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.